期刊文献+

地塞米松治疗前后免疫性血小板减少症患者树突状细胞亚群及细胞因子变化的研究 被引量:8

Changes of dendritic cell subsets and cytokine before and after dexamethasone treatment in ITP patients
下载PDF
导出
摘要 目的探讨免疫性血小板减少症(ITP)患者外周血树突状细胞(DC)亚群的变化及CD80、CD86表达量的改变,进一步检测白细胞介素(IL)-2、IL-4、IL-10及干扰素-γ(IFN-γ)细胞因子含量的变化,并回顾性分析其与地塞米松治疗疗效间的关系。方法留取肝素抗凝的60例ITP患者及10例正常对照者外周血标本,采用流式细胞术检测外周血DC亚群的分布情况,采用ELISA法检测相关细胞因子的含量。结果 ITP患者治疗前较正常对照组DC亚群DC2比例升高(P<0.05),治疗后与正常对照组比较差异无统计学意义;治疗前DC1、DC2上CD80的表达水平较正常对照组升高(P<0.05),DC2细胞上CD86的表达水平较正常对照组升高(P<0.05),地塞米松治疗后表达水平均下降;ITP患者治疗前较正常对照组IL-2、IFN-γ水平升高(P<0.05),地塞米松治疗后表达水平下降;IL-4、IL-10治疗前水平下降(P<0.05),地塞米松治疗后表达水平上升。结论 DC数量与功能的紊乱及IL-2、IL-4、IL-10、IFN-γ的水平变化均参与了ITP的发病,其与地塞米松的疗效可能有重要的联系。 Objective To investigate the changes of dendritic cell subsets and CD80,CD86 expression in peripheral blood in patients with immune thrombocytopenia( ITP),and to evaluate the changes of serum interleukin-2( IL-2),serum interleukin-4( IL-4),serum interleukin-10( IL-10) and interferon-γ( IFN-γ) before and after dexamethasone treatment,overall,further analyzing the relationship between them and dexamethasone. Methods Collecting blood samples of 60 ITP patients and 10 normal controls with heparin anticoagulation,and distribution of dendritic cell subsets of ITP and normal controls was detected by flow cytometry,and the changes of serum IL-2,IL-4,IL-10 and IFN-γ were detected by enzyme linked immunosorbent assay( ELISA). Results The percentage of DC2 was increased in ITP patients compared with the control group( P〈 0. 05) and there was no statistically significont difference after dexamethasone treatment; the expressions of CD80 on DC1 and DC2 were increased compared with the control group( P 〈0. 05),as well as the expression of CD86 on DC2 and the percentage of them decreased after treatment. The serum IL-2,IFN-γ levels before the dexamethasone treatment were higher than the normal control group( P〈0.05),then decreased after treatment. However,the serum IL-4,IL-10 levels were lower than the normal control group before the treatment( P〈0.05),increased after treatment. Conclusion The disorder of the number and function of DCs and the changes of the serum IL-2,IL-4,IL-10 and IFN-γ levels may play important roles in the pathogenesis of ITP. Moreover,there is a probable key relationship between them and the effects of dexamethasone treatment.
出处 《安徽医科大学学报》 CAS 北大核心 2016年第7期998-1001,共4页 Acta Universitatis Medicinalis Anhui
基金 安徽省自然科学基金(编号:1208085MH154)
关键词 免疫性血小板减少症 树突状细胞亚群 细胞因子 地塞米松 immune thrombocytopenic dendritic cell subsets cytokines dexamethasone
  • 相关文献

参考文献12

  • 1l张之南,郝玉书,赵永强.血液病学[M].2版.北京:人民卫生出版社,2012:459-461. 被引量:17
  • 2Frederiksen H, Schmidt K. The incidence of idiopathic thrombocy- topenic purpura in adults increases with age [ J ]. Blood, 1999,94(3) :909 - 13. 被引量:1
  • 3Liu Y J. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity[ J ]. Cell ,2001,106 (3) :259 -62. 被引量:1
  • 4Palucka A K,Blanek J P,Bennett L,et al. Cross-regulation of TNF and IFN-alpha in autoimmune diseases [ J ]. Proc Natl Acad Sci USA, 2005,102 (9) : 3372 - 7. 被引量:1
  • 5凌云,曹祥山,余自强,邱国强,阮长耿.慢性特发性血小板减少性紫癜患者外周血树突细胞的变化及意义[J].中华血液学杂志,2008,29(3):187-191. 被引量:16
  • 6Guo C, Chu X, Shi Y, et al. Correction of Thl-dominant cytokine profiles by high-dose dexamethasone in patients with chronic idio- pathic thrombocytopenic purpura [ J ]. J Clin Immunol, 2007,27 (6) :557 -62. 被引量:1
  • 7Ouabed A, Hubert F X, Chabannes D, et al. Differential control of T regulatory cell proliferation and suppressive activity by mature plasmacytoid versus conventional spleen dendritic cells [ J ]. J Im- munol,2008,180 (9) :5862 - 70. 被引量:1
  • 8Kuwana M, Kawakami Y, Ikeda Y. Suppression of autoreactive T- cell response to glycoprotein Ⅱb/Ⅲa by blockade of CIM0/CD154 interaction : implications for treatment of immune thromboeytopenic purpura[ J ]. Blood,2003,101 (2) :621 - 3. 被引量:1
  • 9Curti A,Trabanelli S,Salvestrini V, et al. The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance : focus on he- matology [ J ]. Blood, 2009,113 ( 11 ) : 2394 - 401. 被引量:1
  • 10李然,瞿文,付蓉,王国锦,王晓明,王化泉,李丽娟,刘鸿,吴玉红,刑莉民,关晶,刘惠,邵宗鸿.免疫性血小板减少症患者树突细胞亚群与淋巴转录因子Gata-3、T—bet的相关性[J].中华医学杂志,2013,93(22):1696-1699. 被引量:6

二级参考文献28

  • 1蔡力生,汪明春,游伟文,李明,聂李平,史敦云.cITP患者糖皮质激素治疗前后Th1/Th2改变[J].临床医学,2005,25(4):13-15. 被引量:3
  • 2凌云,曹祥山,余自强,罗光华,白霞,苏健,戴兰,阮长耿.CD4^+CD25^+调节性T细胞在特发性血小板减少性紫癜患者中的变化[J].中华血液学杂志,2007,28(3):184-188. 被引量:17
  • 3Peng J, Liu CH, Liu D, et al. Effects of B7-blocking agent and/ or CsA on induction of platelet-specific T-cell anergy in chronic autoimmune thrombocytopenic purpura. Blood, 2003, 101 : 2721- 2726. 被引量:1
  • 4Cheng Y, Wong RS, Soo YO, et al. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. N Engl J Med, 2003, 349:831-836. 被引量:1
  • 5Liu YJ. Dendritic cells subsets and lineages, and their functions in innate and adaptive immunity. Cell, 2001,106: 259-262. 被引量:1
  • 6Palucka AK, Blanck JP, Bennett L, et al. Cross-regulation of TNF and IFN- {alpha} in autoimmune diseases. Proc Nail Acid Sci U S A, 2005,102: 3372-3377. 被引量:1
  • 7Paust S, Cantor H. Regulatory T cells and autoimmune disease. Immunol Rev, 2005, 204: 195-207. 被引量:1
  • 8Kingsley CI, Karim M, Bushell AR, et al. CD4^+ CD25^+ regulatory T cells prevent graft rejection: CTLA-4 and IL-10 dependent immunoregulation of alloresponses. J Immunol, 2002, 168 : 1080- 1086. 被引量:1
  • 9Bayry J, Thirion M, Delignat S, et al. Dendritic cells and autoimmunity. Autoimmunol Rev, 2004, 3:183-187. 被引量:1
  • 10Crispin JC, Martinez A, Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmunol, 2003, 21:273-276. 被引量:1

共引文献36

同被引文献63

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部